Share Protection - Financial advisers, investment, wealth management and pensions advice

Share protection through life assurance

Directors' or partners' share agreements may provide for the remaining directors to purchase the shares of other shareholding directors should they die. However there is a risk that the remaining directors may not have sufficient funds to hand when a fellow director passes away unexpectedly.

One solution to this is to take out life cover as a source of funding.

To arrange such cover requires the understanding and agreement of all concerned. It will also require some careful calculations to determine how much cover is required.

However, it will be a comfort to all directors or partners of a business to know that their own or a colleague's death will leave the other directors with sufficient support to carry out the terms of their shareholders' agreement.

This type of policy can also include critical illness for protection in the event that a director or partner is forced to leave due to illness.

The plan will have no cash in value at any time and will cease at the end of the term. If premiums are not maintained, then cover will lapse.

If you wish to register a complaint, please write to admin@bellefinancialservicesltd.com or telephone 01740 644842.

A summary of our internal complaints handling procedures for the reasonable and prompt handling of complaints is available on request and if you cannot settle your complaint with us, you may be entitled to refer it to the Financial Ombudsman Service at www.financial-ombudsman.org.uk or by contacting them on 0800 023 4 567.

Belle Financial Services Ltd: Registered in England & Wales, No. 05058156. Registered address: 1 Church Lane, Eston, Middlesbrough, England, TS6 9DU.

Belle Financial Services Ltd is authorised and regulated by the Financial Conduct Authority. Belle Financial Services Ltd is entered on the FCA register (https://register.fca.org.uk/s/) under reference 959222.

The guidance and/or advice contained within this website is subject to the UK regulatory regime, and is therefore targeted at consumers based in the UK.